Adding elevated Lp(a) concentration to traditional risk factors significantly enhances CV risk estimation in patients with heterozygous familial hypercholesterolaemia (HeFH), according to results of a study in 147 patients clinically diagnosed with HeFH.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
